Spelling suggestions: "subject:"inositol."" "subject:"ionositol.""
31 |
Second messenger pathways involved in peptidergic regulation of the heartWilloughby, Debbie January 1996 (has links)
No description available.
|
32 |
Investigations of Inositol Phosphate-Mediated TranscriptionHatch, Ace Joseph January 2012 (has links)
<p>Inositol phosphates (IPs) are eukaryotic signaling molecules that play important roles in a wide range of biological processes. IPs are required for embryonic development and patterning, insulin secretion, the regulation of telomere length, proper progression through the cell cycle, and the regulation of ion channels. This work uses the yeast Saccharomyces cerevisiae as a model system for investigating the functions of IPs and focuses on the transcriptional regulation of the gene encoding the secreted mating pheromone MFα2 by the IP kinase Ipk2 (also called Arg82, ArgR3, and IPMK). This work shows that Ipk2 has both kinase-dependent and kinase-independent functions in regulating the transcription of MFα2. Transcription of MFα2 is also dependent upon the integrity of an Mcm1-binding site in its promoter. This is the first description of a role for this binding site in the transcription of MFα2. </p><p><italic>In vivo</italic> and <italic>in vitro</italic> screening approaches to identify additional factors associated with MFα2 expression or with IP biology generally are also described. These unbiased approaches provide some valuable insight for further investigations.</p> / Dissertation
|
33 |
Design and synthesis of chemical probes for the plekstrin homology domainElliott, Thomas S. January 2010 (has links)
The phosphatidylinositol polyphosphates play a fundamental role in intracellular signalling. Of particular importance is phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P₃], which acts by recruiting effector proteins to the cell membrane. PtdIns(3,4,5)P₃ interacts with its protein targets through selective binding domains that include the pleckstrin homology (PH) domain. The PH-domain-containing kinase, protein kinase B (PKB/Akt), which interacts with PtdIns(3,4,5)P₃, is upregulated in ~15 human malignancies. Significantly, inhibition of the PtdIns(3,4,5)P₃-PKB interaction has proved viable as a point of therapeutic intervention. There is currently a lack of small molecule probes that selectively interact with a given PH domain. Consequently, it is impossible to dissect the cellular function of PH-domain-containing proteins at a molecular level. To address this problem, we have designed and synthesised a number of derivatives of the PtdIns(3,4,5)P₃ inositol head-group – Ins(1,3,4,5)P₄. Replacement of the 5-position phosphate with a range of phosphate bioisosteres afforded compounds that displayed no binding affinity for the PH-domain of general receptor for phosphoinositides 1 (GRP1). However, it was shown that the 5-position sulfamate analogue displayed selectivity for the PH-domain of PKB. The methylphosphate biosiostere at the 1-position displayed binding for both the GRP1 PH-domain as well as the PKB PH-domain. These results demonstrate that subtle modification of the Ins(1,3,4,5)P₄ structure allows the synthesis of compounds that interact selectively with a given PH domain. We will now use these results for the synthesis of a second generation of compounds with improved PH-domain affinity and selectivity.
|
34 |
Role of myo-inositol in the in-vitro maturation of mammalian oocytes. / CUHK electronic theses & dissertations collectionJanuary 2002 (has links)
by Chiu Tak Yu Tony. / "June 2002." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2002. / Includes bibliographical references (p. 156-182). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.
|
35 |
Cloning and characterisation of a novel 72 kDa inositol polyphosphate 5-phosphataseKong, Anne Mandy, 1973- January 2001 (has links)
Abstract not available
|
36 |
Etude de la régulation et de la surexpression de l'inositol polyphosphate 5-phosphatase SHIP2 chez la souris/Study of the regulation and overexpression of the inositol polyphosphate 5-phosphatase SHIP2 in mice.Blockmans, Marianne C 11 December 2008 (has links)
SHIP2 (SH2 domain-containing inositol polyphosphate 5-phosphatase type 2) est un enzyme de la famille des inositol polyphosphate 5-phosphatases qui déphosphoryle le PtdIns(3,4,5)P3, second messager intervenant dans différentes voies de signalisation cellulaire et impliqué dans de nombreux processus biologiques.
La surexpression de SHIP2 en cellule, de même que son invalidation chez la souris, ont montré un rôle de cet enzyme dans le contrôle négatif de la cascade de signalisation de l’insuline et dans la sensibilité à cette hormone. Par ailleurs, plusieurs études de polymorphismes chez l’homme ont montré une association entre ce gène et le diabète de type2.
La découverte au sein de notre laboratoire de la délétion d’un motif semblable à ceux présents dans les régions déstabilisatrices de type AU-riche dans la région 3’non codante (3’UTR) du gène SHIP2 chez des patients atteints de diabète de type 2, nous a conduit à explorer le rôle de cette région dans le contrôle de l’expression de SHIP2.
Dans ce but, nous avons entrepris d’identifier des protéines capables de lier ce motif AU-riche et d’entraîner l’ARN de SHIP2 vers la dégradation, et ce par deux techniques distinctes : l’une in vivo chez la levure (le triple hybride) et l’autre in vitro, par l’intermédiaire d’une sonde ARN biotinylée. Malheureusement, aucune de ces deux techniques ne nous a permis d’identifier des protéines se liant à l’ARNm de SHIP2. D’autre part, l’analyse de souris génétiquement modifiées présentant dans la région 3’UTR de SHIP2 une mutation similaire à celle observée chez les patients diabétiques n’a pas montré une augmentation significative d’expression de SHIP2 comme on aurait pu s’y attendre.
Malgré les différentes techniques mises en place, nous ne sommes pas parvenus à caractériser le rôle joué par le 3’UTR de SHIP2 sur le contrôle de son expression.
Dans le but de caractériser l’effet d’une surexpression de SHIP2 et de déterminer si une surexpression de ce gène pouvait mimer le phénotype de diabète de type 2 observé au sein de la population, nous avons généré des souris transgéniques d’addition par transgenèse lentivirale.
Deux axes phénotypiques majeurs ont été explorés chez ces souris : le métabolisme du glucose et la prise de poids consécutive à divers régimes alimentaire.
Les souris transgéniques présentent un retard dans la captation du glucose en réponse à une surcharge en glucose, s’accompagnant d’un défaut de sécrétion d’insuline. Par contre, aucune altération de la sensibilité à l’insuline n’est observée suite à une injection de cette hormone. Cette absence d’altération de la sensibilité à l’insuline est également soutenue par le fait qu’aucune altération de la captation de glucose n’est observée chez des souris surexprimant le transgène spécifiquement dans le muscle squelettique.
Les analyses de prise de poids des souris transgéniques ont révélé une résistance à l’obésité des mâles transgéniques lorsqu’ils sont soumis à un régime alimentaire riche en graisse. Par contre, aucune différence n’est observée sous régime alimentaire conventionnel ou faible en graisse. La plus faible prise de poids des souris transgéniques sous régime riche en graisse s’accompagnant d’une plus faible prise de nourriture, un rôle de SHIP2 dans la régulation du comportement alimentaire et de l’appétit n’est pas à exclure.
En conclusion, la surexpression de SHIP2 chez la souris provoque une intolérance au glucose induite, en tout cas en partie, par une plus faible sécrétion d’insuline, ainsi qu’une résistance à l’obésité induite par un régime riche en graisse.
|
37 |
Detection of inositol phosphates with HPLC-ICP-AES : Method developmentWintergerst, Mieke January 2013 (has links)
Inositol phosphates (IPs) represent a major part of the organic phosphorus found in the environment, which makes their identification and quantification very important. The goal of this project was to explore the possibility of quantification of IPs with inductively coupled plasma - atomic emission spectrometry (ICP - AES). This paper deals with the creation of an in-house IP standard and the considerations for the successful linking of high performance liquid chromatography (HPLC) with ICP - AES. Experiments with different nebulizers, mobile phases, standard solutions and model substance were performed. The proposed optimal conditions for the ICP experiments are: the use of a modified Lichte nebulizer, mobile phase without methanol and the use of standards matched to the mobile phase. Adenosine monophosphate (AMP) was found to be a good model substance and showed that the band broadening from HPLC to ICP – AES was approximately a factor of 2. Limits of detection for AMP were 5 µM for HPLC and 20 µM for ICP – AES. The optimal way to create an in-house standard was using the potassium salt of IP6 and treating it for 90 minutes at a temperature of 120 ºC with 3.2 M acetic acid.
|
38 |
Midlife body mass index and cerebral metabolismGonzales, Mitzi Michelle 06 October 2011 (has links)
Obesity is a pervasive condition associated with increased risk of dementia, cognitive impairment, and cerebral atrophy in later life. Given that the pathophysiology underlying obesity’s impact on the central nervous system is poorly understood, the current study examined the association between body mass index (BMI) and five cerebral metabolites of neurobiological significance: N-acetyl-aspartate (NAA), a marker of neuronal viability; choline-containing compounds, free choline, phosphocholine and glycerophosphocholine (Cho), markers of membrane breakdown and turn over; creatine (Cr), a marker of energy metabolism; myo-inositol (mI), an organic osmolyte and substrate for the synthesis of the secondary messenger, inositol triphosphate; and glutamate (Glu), a marker of excitatory neurotransmission and synaptic integrity. Fifty-five participants, aged 40-60 years, underwent neuropsychological testing, health screen and proton magnetic resonance spectroscopy (1H MRS) of the occipitoparietal grey matter. Concentrations of NAA, Cho, mI, and Glu were calculated as a ratio over Cr and examined in relation to BMI using multivariate multiple regression. Higher BMI was associated with elevations in mI/Cr (F(5,47)=3.583, p=0.008, ß=0.387, p=0.006), independent of age, sex, fasting glucose levels, and systolic blood pressure. The current study found that higher BMI is related to increased concentrations of the organic osmoltye and glial marker myo-inositol, potentially implicating plasma hypertonicity and neuroinflammation as mechanisms underlying obesity-related brain dysfunction. With validation and absolute quantification, studies of neurometabolites may improve identification of the pathological mechanisms underlying obesity’s consequences on cognition. / text
|
39 |
The hydrolysis of inositol phospholipid in mouse exocrine pancreas /Tennes, Karin Anne. January 1984 (has links) (PDF)
Thesis (Ph. D.)--University of Adelaide, 1985. / Includes bibliographical references (leaves 358-406).
|
40 |
Characterization of IP₃ receptors in bitter taste transductionClapp, Tod R. January 2004 (has links)
Thesis (Ph. D.)--Colorado State University, 2004. / Includes bibliographical references.
|
Page generated in 0.0307 seconds